摘要新型冠状病毒由于其极强的传染性和极高的突变性，目前已在全球范围内出现多种变异株，给各国的公共卫生系统带来了巨大的威胁和挑战，反复多次感染新型冠状病毒或在全世界成为流行趋势。与非肿瘤患者相比，淋巴瘤患者更易感染新型冠状病毒，预后较差，因此应高度重视对淋巴瘤患者合并新型冠状病毒感染(COVID-19)的临床管理。本文就淋巴瘤合并COVID-19患者的临床特征及目前临床管理策略进行综述，为该类患者的临床治疗提供参考。

abstractsNovel coronavirus has brought great threats to the people and challenges to the health systems around the world. Compared with general population, lymphoma patients are more vulnerable to novel coronavirus infection(COVID-19) and have poorer prognosis. So the clinical management of COVID-19 in lymphoma patients in more difficult and the great importance should be attached. This article reviews the clinical characteristics and current management strategies of lymphoma patients with COVID-19, to provide reference for the clinical treatment of lymphoma patients with COVID-19.